日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Profiles of Asian American parent- and adolescent-reported ethnic-racial socialization: A person-centered analysis

亚裔美国父母和青少年报告的种族社会化特征:以人为中心的分析

Sun, Pearl; Wang, Cixin; Cheah, Charissa S L; Michot, Ashlyn; Wetzel, Louisa

STELLAR-305: phase II/III study of zanzalintinib plus pembrolizumab versus pembrolizumab alone in patients with HNSCC

STELLAR-305:一项针对头颈部鳞状细胞癌患者的扎扎林替尼联合帕博利珠单抗与帕博利珠单抗单药治疗的II/III期研究

Saba, Nabil F; Harrington, Kevin; Licitra, Lisa; Machiels, Jean-Pascal; He, Cixin; Jew, Taylor; Andrianov, Vasily; Haddad, Robert

A Phase 1/2 Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric and Young Adult Solid Tumors

乐伐替尼联合依维莫司治疗复发性和难治性儿童及青少年实体瘤的1/2期研究

Dela Cruz, Filemon S; Fox, Elizabeth; DuBois, Steven G; Friedman, Gregory K; Croop, James M; Kim, AeRang; Morgenstern, Daniel A; Balis, Frank M; Macy, Margaret E; Pressey, Joseph G; Watt, Tanya; Krystal, Julie I; Vo, Kieuhoa T; Mody, Rajen; Laetsch, Theodore W; Weigel, Brenda J; O'Hara, Karen; He, Cixin S; Aluri, Jagadeesh; Okpara, Chinyere E; Glade Bender, Julia L

Microwave-Assisted Synthesis of MoS(2)/BiVO(4) Heterojunction for Photocatalytic Degradation of Tetracycline Hydrochloride

微波辅助合成MoS(2)/BiVO(4)异质结用于光催化降解盐酸四环素

Cheng, Cixin; Shi, Qin; Zhu, Weiwei; Zhang, Yuheng; Su, Wanyi; Lu, Zizheng; Yan, Jun; Chen, Kao; Wang, Qi; Li, Junshan

Phase 3 CLEAR study in patients with advanced renal cell carcinoma: outcomes in subgroups for the lenvatinib-plus-pembrolizumab and sunitinib arms

CLEAR III期研究在晚期肾细胞癌患者中的应用:乐伐替尼联合帕博利珠单抗组和舒尼替尼组的亚组疗效

Grünwald, Viktor; Powles, Thomas; Eto, Masatoshi; Kopyltsov, Evgeny; Rha, Sun Young; Porta, Camillo; Motzer, Robert; Hutson, Thomas E; Méndez-Vidal, María José; Hong, Sung-Hoo; Winquist, Eric; Goh, Jeffrey C; Maroto, Pablo; Buchler, Tomas; Takagi, Toshio; Burgents, Joseph E; Perini, Rodolfo; He, Cixin; Okpara, Chinyere E; McKenzie, Jodi; Choueiri, Toni K

Corrigendum: Phase 3 CLEAR study in patients with advanced renal cell carcinoma: outcomes in subgroups for the lenvatinib-plus-pembrolizumab and sunitinib arms

更正:CLEAR III期研究(晚期肾细胞癌患者):乐伐替尼联合帕博利珠单抗组和舒尼替尼组的亚组结果

Grünwald, Viktor; Powles, Thomas; Eto, Masatoshi; Kopyltsov, Evgeny; Rha, Sun Young; Porta, Camillo; Motzer, Robert; Hutson, Thomas E; Méndez-Vidal, María José; Hong, Sung-Hoo; Winquist, Eric; Goh, Jeffrey C; Maroto, Pablo; Buchler, Tomas; Takagi, Toshio; Burgents, Joseph E; Perini, Rodolfo; He, Cixin; Okpara, Chinyere E; McKenzie, Jodi; Choueiri, Toni K

The relations between COVID-19 stress, social connectedness, and mental health: a longitudinal investigation comparing Chinese and American college students

新冠疫情压力、社会联系与心理健康之间的关系:一项比较中国和美国大学生的纵向研究

Wang, Cixin; Havewala, Mazneen; Fan, Qingyue; Wang, Qing; Bali, Diksha

Asian American University Students' Adjustment, Coping, and Stress during the COVID-19 Pandemic

亚裔美国大学生在新冠疫情期间的适应、应对和压力

Hwang, Jacqueline; Ding, Yi; Chen, Eric; Wang, Cixin; Wu, Ying

COVID-19 Racism and Chinese American Families' Mental Health: A Comparison between 2020 and 2021

新冠疫情下的种族歧视与美籍华人家庭的心理健康:2020 年与 2021 年的比较

Cheah, Charissa S L; Ren, Huiguang; Zong, Xiaoli; Wang, Cixin

Health-related quality-of-life outcomes in patients with advanced renal cell carcinoma treated with lenvatinib plus pembrolizumab or everolimus versus sunitinib (CLEAR): a randomised, phase 3 study

一项随机、3期研究(CLEAR):比较乐伐替尼联合帕博利珠单抗或依维莫司治疗晚期肾细胞癌患者的健康相关生活质量结局与舒尼替尼单药治疗的疗效。

Motzer, Robert; Porta, Camillo; Alekseev, Boris; Rha, Sun Young; Choueiri, Toni K; Mendez-Vidal, Maria Jose; Hong, Sung-Hoo; Kapoor, Anil; Goh, Jeffrey C; Eto, Masatoshi; Bennett, Lee; Wang, Jinyi; Pan, Jie Janice; Saretsky, Todd L; Perini, Rodolfo F; He, Cixin Steven; Mody, Kalgi; Cella, David